ORL Hals

En | De
Sie sind hier: ORL » Hals 30. September 2022
Erweiterte Suche
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 378  vorhergehende Seite nächste Seite
   Artikel 1 - 20 / 7547  
Survey on determinants of intention to reduce nasopharyngeal cancer risk: an application of the theory of planned behavior.
BMC Public Health
Ting SH, Brahmana RK, Jerome C, Podin Y.
PMID: 36123661 [PubMed - indexed for MEDLINE]

Development and validation of the health belief model questionnaire to promote smoking cessation for nasopharyngeal cancer prevention: a cross-sectional study.
BMJ Open
Kueh MTW, Rahim FF, Rashid A.
PMID: 36104123 [PubMed - indexed for MEDLINE]

Uncovering nasopharyngeal carcinoma from chronic rhinosinusitis and healthy subjects using routine medical tests via machine learning.
PLoS One
Liu Q, Du J, Li Y, Peng G, Wang X, Zhong Y, Du R.
PMID: 36083977 [PubMed - indexed for MEDLINE]

Prognostic Relevance of Change in Body Mass Index in Patients With Nasopharyngeal Carcinoma Undergoing Volumetric Modulated Arc Therapy: A Retrospective Study.
Cancer Control
Lin X, Wang B, Zheng F, Fei Z, Chen C.
PMID: 36075003 [PubMed - indexed for MEDLINE]

Current approach of juvenile nasopharyngeal angiofibroma: a case series.
Rom J Morphol Embryol
Vl, Ioni, Ciolofan MS, Mogoant, Voiosu C, Rusescu A, Hain.
PMID: 36074673 [PubMed - indexed for MEDLINE]

Efficacy of Cetuximab in Nasopharyngeal Carcinoma Patients Receiving Concurrent Cisplatin-Radiotherapy: A Meta-Analysis.
Comput Math Methods Med
Wang L, Liu D, Wei D.
PMID: 36060662 [PubMed - indexed for MEDLINE]

First-Line Immunochemotherapy Versus Palliative Chemotherapy Plus Definitive Radiation Therapy for de novo Metastatic Nasopharyngeal Carcinoma: A Matched Cohort Study.
Cancer Control
Yang ZC, Liu T, Chen YZ, Guo CY, Liu LT, Liu SL, Chen QY, Mai HQ, Guo SS.
PMID: 36047451 [PubMed - indexed for MEDLINE]

Indoleamine 2,3-dioxygenase gene expression and kynurenine to tryptophan ratio correlation with nasopharyngeal carcinoma progression and survival.
Immun Inflamm Dis
Souissi S, Ghedira R, Macherki Y, Ben-Haj-Ayed A, Gabbouj S, Remadi Y, Sfar I, Chadli Z, Aouam K, Hassine M, Bouaouina N, Zakhama A, Hassen E.
PMID: 36039641 [PubMed - indexed for MEDLINE]

Establishment and Validation of a Predictive Model for Radiation-Associated Aspiration Pneumonia in Patients with Radiation-Induced Dysphagia after Nasopharyngeal Carcinoma.
Behav Neurol
Li H, He Y, Zhuo X, Yue Z, Rong X, Li Y, Li Y, He L, Cheng J, Pan D, Xue R, Cai J, Jiang J, Xu Y, Tang Y.
PMID: 36039334 [PubMed - indexed for MEDLINE]

A diagnosis model in nasopharyngeal carcinoma based on PET/MRI radiomics and semiquantitative parameters.
BMC Med Imaging
Feng Q, Liang J, Wang L, Ge X, Ding Z, Wu H.
PMID: 36038819 [PubMed - indexed for MEDLINE]

Induction versus adjuvant chemotherapy combined with concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: a retrospective cohort study.
Aging (Albany NY)
Mu X, Liu H, Wu J, Chen S, Peng X, Wang J, Wei Z, He L, Liu J, Lu Z, Su Y.
PMID: 36036759 [PubMed - indexed for MEDLINE]

The global, regional, and national burden of nasopharyngeal carcinoma and its attributable risk factors in 204 countries and territories, 1990-2019.
Acta Otolaryngol
Zhang Y, Cao Y, Luo L, Li J, Wang L, Lu Y, Gu S, Deng H, Shen Z.
PMID: 36018303 [PubMed - indexed for MEDLINE]

Nimotuzumab plus induction chemotherapy followed by radiotherapy/concurrent chemoradiotherapy plus nimotuzumab for locally advanced nasopharyngeal carcinoma: protocol of a multicentre, open-label, single-arm, prospective phase II trial.
BMJ Open
Yuan JJ, Ding JW, Li JW, Hu RH, Gong D, Hu JL, Zhu KB, Liu Y, Ding YH, Wei JW, Zeng JL, Lu ZB, Yin WH, Ai SF, Zha GH, Zhang ZL, Zou R, Zeng L.
PMID: 36008072 [PubMed - indexed for MEDLINE]

A two-stage genome-wide association study to identify novel genetic loci associated with acute radiotherapy toxicity in nasopharyngeal carcinoma.
Mol Cancer
Wang Y, Xiao F, Zhao Y, Mao CX, Yu LL, Wang LY, Xiao Q, Liu R, Li X, McLeod HL, Hu BW, Huang YL, Lv QL, Xie XX, Huang WH, Zhang W, Guo CX, Li JG, Yin JY.
PMID: 35999636 [PubMed - indexed for MEDLINE]

Effect of Radiotherapy Alone vs Radiotherapy With Concurrent Chemoradiotherapy on Survival Without Disease Relapse in Patients With Low-risk Nasopharyngeal Carcinoma: A Randomized Clinical Trial.
Tang LL, Guo R, Zhang N, Deng B, Chen L, Cheng ZB, Huang J, Hu WH, Huang SH, Luo WJ, Liang JH, Zheng YM, Zhang F, Mao YP, Li WF, Zhou GQ, Liu X, Chen YP, Xu C, Lin L, Liu Q, Du XJ, Zhang Y, Sun Y, Ma J.
PMID: 35997729 [PubMed - indexed for MEDLINE]

Improving on-treatment risk stratification of cancer patients with refined response classification and integration of circulating tumor DNA kinetics.
Lv J, Wu C, Li J, Chen F, He S, He Q, Zhou G, Ma J, Sun Y, Wei D, Lin L.
PMID: 35996151 [PubMed - indexed for MEDLINE]

Linc00312 Single Nucleotide Polymorphism as Biomarker for Chemoradiotherapy Induced Hematotoxicity in Nasopharyngeal Carcinoma Patients.
Dis Markers
Guo Z, Wang YJ, He BS, Zhou J.
PMID: 35990252 [PubMed - indexed for MEDLINE]

The use of SN-5 to differentiate chronic rhinosinusitis and chronic adenoiditis in children.
Int J Pediatr Otorhinolaryngol
Orabi NA, Makary CA, Ramadan HH.
PMID: 35987130 [PubMed - indexed for MEDLINE]

Cadonilimab: First Approval.
Keam SJ.
PMID: 35986837 [PubMed - indexed for MEDLINE]

Arterial spin labeling and diffusion-weighted imaging for identification of retropharyngeal lymph nodes in patients with nasopharyngeal carcinoma.
Cancer Imaging
Yu X, Yang F, Liu X, Zhao Y, Li Y, Lin M, Xie L, Shang Y.
PMID: 35978445 [PubMed - indexed for MEDLINE]

   Artikel 1 - 20 / 7547    Seite 1 von 378  vorhergehende Seite nächste Seite

Rect Bottom
Adserver Footer





Haben Sie Ihr Passwort vergessen?


Neu bei My Medline?

Melden Sie sich bei My Medline an!


Mehr über My Medline erfahren

mehr >>


Benutzen Sie englische Suchbegriffe für Ihre Suche in



mehr >>


Sky right 1